CAS NO: 1809249-37-3
Molecular weight: 602.58
Molecular formula: c27H35N6O8P
current content: 98% HPLC
Product status: produce
Description: Remdesivir, a nucleoside analogue, is an RNA-dependent RNA polymerase (RdRp) inhibitor that can inhibit viral nucleic acid synthesis. The clinical Chemicalbook study for Ebola virus infection is currently in phase II. Mice infected with MERS did much better with the combination therapy, with reduced viral replication and improved lung function. Recent studies have shown that Redesivir has a certain active effect on inhibiting the novel coronavirus.
